3858 results for «2287»

Filter By

3858 results

Physiology or intracoronary imaging; or both? or none? - part 2

27 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on physiology and intracoronary imaging presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: SOCT-PCI Study, impact of PPG index on PCI, angiography-derived IMR.

Physiology or intracoronary imaging; or both? or none?

Vulnerable plaques and vulnerable patients

27 Jun 2020 – From PCR e-Course 2020

Watch this session to learn more about latest advances in detecting and treating vulnerable plaques and patients, in predicting clinical events, and the imaging options for prevention and treatment.

This session was originally presented during PCR e-Course 2020.

Vulnerable plaques and vulnerable patients

PCR e-Course 2020: Opening Ceremony - Education & Innovation in Interventional Cardiovascular Medicine

25 Jun 2020 – From PCR e-Course 2020

View the opening ceremony of this brand new digital initiative for the interventional cardiovascular community. Innovation, scientific news and best practice from across the globe!

PCR e-Course 2020: Opening Ceremony - Education & Innovation in Interventional Cardiovascular Medicine

PCR e-Course 2020 Clinical cases

25 Jun 2020 – From PCR e-Course 2020

Watch a series of best clinical cases presented at the PCR e-Course 2020:

  • ACS-patient with culprit in a coronary ectasia
  • Coronary stenting in an ectatic artery
  • Challenging PCI after aortic valve-in-valve implantation
  • Cisplatin-induced coronary artery thrombosis presented as ACS
  • MOCA I study: microvascular obstruction measured using dMVR
  • The many faces of in-stent...
PCR e-Course Clinical cases

The burden of non-COVID patients: caring for the left-behind

26 Jun 2020 – From PCR e-Course 2020

Despite the dramatic consequences of the pandemic, there is still a need for treating chronic cardiovascular diseases. In this session, you will find out more about the strategies that can be used to deal with the people left behind.

This session was originally presented during PCR e-Course...

The burden of non-COVID patients: caring for the left-behind

The resurgence of renal denervation

25 Jun 2020 – From PCR e-Course

Following the latest trial results showing the safety and efficacy of renal denervation to treat hypertension, this session will provide you with a high-level update on where we stand currently and where we are moving in the near future.

This session was originally presented during PCR e-Course...

The resurgence of renal denervation

Complications in complex interventions

21 May 2019 – From EuroPCR 2019

Consult this session to learn more about how to manage complications in complex interventions, such as a retrograde recanalisation of the right coronary artery complicated by intraprocedural cardiac arrest, an acute and chronic radiation injury following complex PCI, and more!

Complications in complex interventions

Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation

25 Jun 2020 – From PCR e-Course 2020

A  common  exclusion  for  transcatheter  mitral  valve  implantation  (TMVI)  is  a  small  predicted  neo-left  ventricular  outflow  tract  (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...

LVESD screening determines anatomic suitability for TMVI

Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation

Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.

Videos included on this page: the Hot Line presentation and...

Two-year outcomes of

New TMVI therapy to eliminate mitral regurgitation. Evidence and patient selection

26 Jun 2020 – From PCR e-Course 2020

Watch this video if you want to get the latest update on the first commercially available TMVI therapy (Tendyne), to learn about Tendyne clinical experience and how to identify the best candidates for this novel therapy.

New TMVI Therapy to eliminate mitral regurgitation: evidence and patient selection

Shaping care pathways for severe aortic stenosis patients in a COVID-19 context

Watch this roundtable discussion on the management of aortic stenosis in the context of the COVID-19 pandemic and how to readdress the treatment options and pathways to serve the needs of the patients in this difficult global crisis.

Shaping care pathways for severe aortic stenosis patients in a COVID-19 context

PCR e-Course Hot lines: drugs and devices for STEMI management

Watch this session to know more about ultrathin-strut vs thin-strut DES in patients with STEMI undergoing percutaneous coronary intervention (BIOSTEMI), RCT between bioresorbable and durable polymer stent by serial OCT assessment (MECHANISM-AMI), and the results of the FUNCOMBO trial.

Hot line: drugs and devices for STEMI management

Physiology or intracoronary imaging; or both? or none? - part 1

27 Jun 2020 – From PCR e-Course 2020

Watch a series of studies on physiology and intracoronary imaging presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: SCAAR report, a sub-analysis of the FORZA trial, diagnostic accuracy of IVUS-based FFR.

Physiology or intracoronary imaging; or both? or none?

Hot line on PCI: high bleeding risk and DAPT - part 2

27 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on high bleeding risk and DAPT presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: TWILIGHT CHINA, SMART-CHOICE, LEADERS FREE III.

Hot lines on PCI: high bleeding risk and DAPT

Ultrathin-strut vs. thin-strut DES for primary PCI

27 Jun 2020 – From PCR e-Course 2020

Watch this session to review the role of ultrathin DES in optimising clinical outcomes for STEMI patients, to assess the impact of the BIOSTEMI trial to daily practice and to learn about real-world challenges when treating STEMI patients.

Videos included on this page: the Hot Line presentation...

Ultrathin-strut vs. thin-strut DES for primary PCI

Controversies in antiplatelet therapy for secondary prevention of coronary artery events

26 Jun 2020 – From PCR e-Course

Watch this session if you want to understand more about the guidelines for antiplatelet secondary prevention of ACS/PC and to review available data on antiplatelet therapy after ACS/PCI.

Controversies in Antiplatelet Therapy for the Secondary Prevention of Cardiovascular Events

PCR e-Course 2020 Late-Breaking Trials – part 1

26 Jun 2020 – From PCR e-Course 2020

Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice: 

  • Crossover results from the RADIANCE-HTN SOLO trial
  • DynamX Bioadaptor, a novel « uncaging » platform
  • Two-stent vs. provisional for bifurcation PCI: the DEFINITION II trial
PCR e-Course 2020 Late-Breaking Trials

Hot lines on Mitral interventions – part 1

25 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on mitral interventions presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: EVOQUE replacement, Tendyne TMVI, CLASP, V-i-V and V-i-R, Tendyne MAC.

Hot Lines on mitral interventions

Portico FlexNav - Optimise TAVI outcomes from routine to complex cases

Watch this session if you want to learn how Portico enables you to achieve favorable haemodynamics and patient outcomes, to learn about the new Portico with FlexNav TAVI system and its deliverability and to learn the importance of looking ahead during transcatheter aortic valve implantation and...

Portico FlexNav - Optimise TAVI outcomes from routine to complex cases

PCR e-Course Hot Lines in STEMI interventions: First-in-Man and novel pharmacological strategies

27 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines in STEMI interventions presented during PCR e-Course 2020, followed by an analysis of these results and their impact on your practice: MOCA I Study, ON-TIME 3 trial, FABOLUS FASTER.

STEMI interventions: First-in-Man and novel pharmacological strategies
Didn’t find what you were looking for?